All tools
Educational use only. Not a substitute for clinical judgment. Always verify independently.

Beta-Blocker Equivalency

Convert between metoprolol, carvedilol, bisoprolol, atenolol, propranolol, nebivolol, and labetalol with HF target-dose context.

mg/day
DrugDaily doseSchedule
Metoprolol succinate (XL)100mg/daydaily
Metoprolol tartrate (IR)100mg/dayBID
Carvedilol25mg/dayBID
Bisoprolol5mg/daydaily
Atenolol50mg/daydaily
Propranolol80mg/dayTID–QID (IR)
Nebivolol5mg/daydaily
Labetalol200mg/dayBID

Target dose for HFrEF

Guideline-directed target for Metoprolol succinate (XL): 200 mg/day (MERIT-HF target). Your input is 50% of target.

Cross-class equivalency is approximate

  • Carvedilol and labetalol have α-blockade — they lower BP more than a pure β1 conversion suggests.
  • Receptor selectivity (β1 vs non-selective) matters in asthma, hyperthyroidism, and migraine.
  • Metoprolol succinate (XL) is once-daily; tartrate is BID — total daily dose is roughly equivalent but PK is not.
  • For HFrEF, only the four trial-validated agents (carvedilol, metoprolol succinate, bisoprolol, nebivolol in HFpEF/elderly) carry mortality benefit.
Updated 2026-04-28Report an error